These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 20615154

  • 21. Optimization and prediction of drug release from matrix tablets using response surface methodology and near infrared chemical imaging.
    Bagchi S, Li W, Plakogiannis F.
    Pharm Dev Technol; 2012; 17(4):398-406. PubMed ID: 21222508
    [Abstract] [Full Text] [Related]

  • 22. Surelease or organic solution of ethylcellulose in preparation of sustained release theophylline micromatrices or matrices using spray drying technique.
    Afrasiabi Garekani H, Sedighi S, Sadeghi F.
    Pharm Dev Technol; 2015 Mar; 20(2):204-10. PubMed ID: 24286215
    [Abstract] [Full Text] [Related]

  • 23. [The erosion behaviour of matrix tablets using polyethylene oxide matrices as hydrophilic polymer].
    Nie SF, Tang H, Guo H, Pan WS.
    Yao Xue Xue Bao; 2005 Oct; 40(10):882-7. PubMed ID: 16408802
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of hot-melt extrusion and injection molding for continuous manufacturing of immediate-release tablets.
    Melocchi A, Loreti G, Del Curto MD, Maroni A, Gazzaniga A, Zema L.
    J Pharm Sci; 2015 Jun; 104(6):1971-1980. PubMed ID: 25761921
    [Abstract] [Full Text] [Related]

  • 25. In vitro and in vivo evaluation of controlled-release matrix tablets of highly water-soluble drug applying different mw polyethylene oxides (PEO) as retardants.
    Wen H, Li X, Li Y, Wang H, Wang Y, Wang T, Pan W, Yang X.
    Drug Dev Ind Pharm; 2018 Apr; 44(4):544-552. PubMed ID: 29130753
    [Abstract] [Full Text] [Related]

  • 26. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H, Yoshihara K, Sawada T, Kondo H, Sako K.
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [Abstract] [Full Text] [Related]

  • 27. Prilling of fatty acids as a continuous process for the development of controlled release multiparticulate dosage forms.
    Vervaeck A, Saerens L, De Geest BG, De Beer T, Carleer R, Adriaensens P, Remon JP, Vervaet C.
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):587-96. PubMed ID: 23474381
    [Abstract] [Full Text] [Related]

  • 28. Modeling drug release from hot-melt extruded mini-matrices with constant and non-constant diffusivities.
    Verhoeven E, Siepmann F, De Beer TR, Van Loo D, Van den Mooter G, Remon JP, Siepmann J, Vervaet C.
    Eur J Pharm Biopharm; 2009 Oct; 73(2):292-301. PubMed ID: 19549569
    [Abstract] [Full Text] [Related]

  • 29. Formulation, in vitro evaluation and study of variables on tri-layered gastro-retentive delivery system of diltiazem HCl.
    Raut Desai S, Rohera BD.
    Drug Dev Ind Pharm; 2014 Mar; 40(3):380-9. PubMed ID: 23369093
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Raman spectroscopy for the in-line polymer-drug quantification and solid state characterization during a pharmaceutical hot-melt extrusion process.
    Saerens L, Dierickx L, Lenain B, Vervaet C, Remon JP, De Beer T.
    Eur J Pharm Biopharm; 2011 Jan; 77(1):158-63. PubMed ID: 20933084
    [Abstract] [Full Text] [Related]

  • 33. Dissolution kinetics and physical characterization of three-layered tablet with poly(ethylene oxide) core matrix capped by Carbopol.
    Hong SI, Oh SY.
    Int J Pharm; 2008 May 22; 356(1-2):121-9. PubMed ID: 18272308
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Assessment of hot-processability and performance of ethylcellulose-based materials for injection-molded prolonged-release systems: An investigational approach.
    Casati F, Briatico-Vangosa F, Baldi F, Melocchi A, Maroni A, Gazzaniga A, Zema L.
    Int J Pharm; 2018 Sep 05; 548(1):400-407. PubMed ID: 29981413
    [Abstract] [Full Text] [Related]

  • 38. Calendering as a direct shaping tool for the continuous production of fixed-dose combination products via co-extrusion.
    Vynckier AK, Lin H, Zeitler JA, Willart JF, Bongaers E, Voorspoels J, Remon JP, Vervaet C.
    Eur J Pharm Biopharm; 2015 Oct 05; 96():125-31. PubMed ID: 26232550
    [Abstract] [Full Text] [Related]

  • 39. Robustness of barrier membrane coated metoprolol tartrate matrix tablets: Drug release evaluation under physiologically relevant in vitro conditions.
    Klein S, Seeger N, Mehta R, Missaghi S, Grybos R, Rajabi-Siahboomi A.
    Int J Pharm; 2018 May 30; 543(1-2):368-375. PubMed ID: 29630933
    [Abstract] [Full Text] [Related]

  • 40. Upscaling and in-line process monitoring via spectroscopic techniques of ethylene vinyl acetate hot-melt extruded formulations.
    Almeida A, Saerens L, De Beer T, Remon JP, Vervaet C.
    Int J Pharm; 2012 Dec 15; 439(1-2):223-9. PubMed ID: 23018111
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.